Page 155 - metagenics-catalogue_c_en_5

MenoHop 30C

Product description

MenoHop helps to attenuate the symptoms of transition. In MenoHop, 2 very
powerful phyto-estrogens are combined: hops and soy. The estrogenic effects
of hops have been known for many years among hop
pickers. They often experienced disturbances in the menstrual cycle, which
shows the endocrine effect of the hops. A research team in Ghent managed to
isolate the molecule 8-prenylnaringenin (8-PN) or hopein from hops, the most
powerful phytoestrogen known up til now. Hopein helps to reduce short-term
complaints during menopause, such as hot flushes, irritability and insomnia.
The production and application process of 8-PN is patented by Metagenics. In
MenoHop, hopein is combined with soy extract, another phyto-estrogen which is
very rich in isoflavones. Scientific research has shown several long-term
health promoting properties of isoflavones, both in the prevention of
osteoporosis and to decrease the risk of cardiovascular incidents.

Ingredients
INGREDIENTS PER CAPSULE

Hops extract (Humulus lupulus) standardized at hopein 200 mg
8-prenylnaringenin 200 µg
Soy extract (Glycine max) standardized at isoflavones 50 mg
soy isoflavones 20 mg
Excipients: dicalcium phosphate, gelatin, magnesium stearate, silicium
dioxide, coloring capsule: iron oxide and titanium dioxide

Packaging

30 capsules
Recommended use

1 capsule daily or as recommended

Precaution

Must not be used in case of pregnancy or history of hormone dependant
cancers.

Metagenics Europe | info@metagenics.eu | +32(0)59/80.58.24 | www.metagenics.eu Drawn Up 15/12/2012 MenoHop 30C 7672
The information given in this publication is intended explicitly for readers who deal with health and nutrition on professional grounds. In the interest of public health this publication is not intended
for lay people or consumers. Publisher and authors declare that this publication has been compiled meticulously and to the best of their knowledge. However, they cannot be held responsible for
the comprehensiveness or potential mistakes of this publication. Publisher and authors do not accept any responsibility for damage, of any kind, resulting from actions and/or decisions based on the
contents of this publication.